How This Works
Selank is a synthetic analog of the immunomodulatory peptide tuftsin, consisting of the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. In Russian clinical trials for anxiety disorders and neurasthenia, intranasal Selank produced anxiolytic effects comparable to benzodiazepines while also providing anti-asthenic (energy-boosting) benefits without sedative observations or dependence potential[1][2]. Preclinical studies in primates demonstrated that intranasal Selank eliminated fear and anxiety behaviors with long-term stabilizing effects on neurobehavior[4]. Rodent studies confirmed robust anxiolytic efficacy comparable to classical tranquilizers[5]. While most published human data utilized intranasal measurement (the original formulation), preparation has shown effectiveness in research settings with consistent absorption and ease of dose measurement[3].
References
PubMed
— Clinical trial of Selank for generalized anxiety disorder (intranasal, human study)
PubMed
— Selank for neurasthenia: 14-day clinical trial demonstrating anxiolytic and anti-asthenic effects (human study)
Hindawi BioMed Research
— Intranasal Selank preparation review: neurobehavioral effects and clinical applications (review article)
Springer
— Primate studies: intranasal Selank eliminates anxiety behaviors with long-term effects (preclinical)
Springer
— Selank attenuates opioid withdrawal symptoms in animal models (preclinical measurement study)
CDC
— Vaccine preparation best practices: handling reference and site selection
Cleveland Clinic
— measurement guide: technique, sites, and rotation principles
NCBI Bookshelf
— Clinical procedures: measurement preparation, aseptic technique, and preparation standards
CDC
— Measurement safety guidelines: single-use devices, sharps disposal, and preventing unsafe practices
NIBSC
— Peptide storage guidelines: lyophilized and reconstituted stability considerations
PMC
— Pharmacologic review: drug delivery and absorption considerations
